4563
AnGes,Inc.
アンジェス
- Industry
- Pharmaceutical
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Dec 2021
64,148
Dec 2022
67,061
Dec 2023
152,985
Dec 2024
643,638
Dec 2025
874,120
Operating profit(thousand JPY)
Dec 2021
-15,632,085
Dec 2022
-16,316,803
Dec 2023
-11,967,504
Dec 2024
-9,109,445
Dec 2025
-5,145,393
Operating profit margin(%)
Dec 2021
-24,368.78
Dec 2022
-24,331.28
Dec 2023
-7,822.66
Dec 2024
-1,415.31
Dec 2025
-588.64
Profit before tax(thousand JPY)
Dec 2021
-13,735,294
Dec 2022
-14,716,994
Dec 2023
-7,471,415
Dec 2024
-27,643,667
Dec 2025
-5,236,583
Profit(thousand JPY)
Dec 2021
-13,675,587
Dec 2022
-14,714,772
Dec 2023
-7,437,607
Dec 2024
-28,128,983
Dec 2025
-5,123,269
Total assets(thousand JPY)
Dec 2021
45,455,746
Dec 2022
38,820,711
Dec 2023
28,892,536
Dec 2024
4,668,599
Dec 2025
5,405,983
Cash and cash equivalents(thousand JPY)
Dec 2021
17,835,704
Dec 2022
10,969,684
Dec 2023
4,092,160
Dec 2024
1,627,669
Dec 2025
1,796,068
Cash flows from operating activities(thousand JPY)
Dec 2021
-11,380,546
Dec 2022
-11,214,246
Dec 2023
-8,745,759
Dec 2024
-6,612,875
Dec 2025
-5,750,366
Cash flows from investing activities(thousand JPY)
Dec 2021
-154,873
Dec 2022
-97,141
Dec 2023
-356,653
Dec 2024
-130,801
Dec 2025
18,814
Cash flows from financing activities(thousand JPY)
Dec 2021
17,378,670
Dec 2022
3,572,543
Dec 2023
2,036,465
Dec 2024
4,202,127
Dec 2025
5,902,042
Return on equity(-)
Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-
Equity ratio(%)
Dec 2021
84.8
Dec 2022
78.1
Dec 2023
90
Dec 2024
44
Dec 2025
55.2
Earnings per share(JPY per share)
Dec 2021
-92.86
Dec 2022
-94.29
Dec 2023
-39.29
Dec 2024
-119.53
Dec 2025
-14.44
Net assets per share(JPY per share)
Dec 2021
251.81
Dec 2022
169.77
Dec 2023
131.04
Dec 2024
7.17
Dec 2025
7.67
Dividend per share(-)
Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-
Payout ratio(-)
Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.